Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

27 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Extended Data Exclusivity Period for Pharmaceuticals

    The data exclusivity period applicable to pharmaceuticals for human use is to be extended by the introduction of an 8+2+1 rule to replace the current 6-year exclusivity period.
    PolandFood, Drugs, Healthcare, Life Sciences
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    New Restrictions On The Sale Of Energy Drinks In Poland

    The sale of popular drinks containing taurine and caffeine, commonly referred to as "energy drinks", has been limited from 1 January 2024 in accordance with provisions introduced in the Act of 17...
    PolandFood, Drugs, Healthcare, Life Sciences
    Schoenherr (Schönherr Rechtsanwälte)
    Schoenherr (Schönherr Rechtsanwälte)
  • Article

    General Prohibition Of Advertising Of Dental Care Services Incompatible With The European Law

    The CJEU also stated that the article 56 of The Treaty on the Functioning of the European Union must be interpreted as precluding national legislation which imposes a general and absolute prohibition...
    European UnionMedia, Telecoms, IT, Entertainment
    Czyzewscy Kancelaria Adwokacka
    Czyzewscy Kancelaria Adwokacka
  • Article

    New Limits On Pharmaceutical Samples

    From 1 January 2012, doctors will only be able to obtain a medicinal product sample for 2 years after first requesting it, and will be limited to a maximum of 4 samples per year.
    PolandFood, Drugs, Healthcare, Life Sciences
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    What Does A Compulsory License Have In Common With A Fig Leaf?

    The pharmaceutical industry has extremely quickly responded to the challenges posed by the COVID-19 pandemic.
    PolandIntellectual Property
    JWP Patent & Trademark Attorneys sp.k.
    JWP Patent & Trademark Attorneys sp.k.
  • Article

    ZUS And NFZ To Interpret Social And Health Insurance Regulations

    From 20 September 2008, the Social Insurance Institution (ZUS) and the National Health Fund (NFZ) will give businesses interpretations of social and health insurance regulations as they apply to current or future events.
    PolandTax
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    Amendment To The Act On Trade Quality Of Foodstuffs

    Following lengthy parliamentary discussions and an increasing number of complaints as to the quality of foodstuffs available on the Polish market, a significant amendment to the Act on Trade Quality of Foodstuffs entered into force on 18 December 2008.
    PolandConsumer Protection
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    New Alcohol Labelling Rules

    The labels on alcoholic beverages may soon be required to include health warnings, under draft amendments being considered by the Polish parliament.
    PolandConsumer Protection
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    Corruption In Clinical Trials

    Changes may be made to the way clinical trials are financed, supervised and conducted following an inspection of 13 clinical hospitals by the Supreme Audit Office (NIK).
    PolandFood, Drugs, Healthcare, Life Sciences
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    New 5-Year Retention Period For Clinical Trial Documents

    From 22 March 2010, the period for which sponsors must keep basic documentation of a clinical trial will be extended from two to five years.
    PolandFood, Drugs, Healthcare, Life Sciences
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    New Rules For Dietary Supplements

    From 4 June 2010, new rules apply to the composition and labeling of dietary supplements.
    PolandFood, Drugs, Healthcare, Life Sciences
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    Amendment To The Food Safety Act

    Foodstuffs such as dietary supplements may be subject to amended procedure where there are concerns whether they meet the criteria for medicinal products.
    PolandFood, Drugs, Healthcare, Life Sciences
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    New Reimbursement Procedure For Medicinal Products

    The Polish Parliament adopted a new law governing the reimbursement of medicinal products, medical devices and food for special medical purposes.
    PolandFood, Drugs, Healthcare, Life Sciences
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    Call For EU Ban On Food Colourings Linked To Hyperactivity

    The European Food Standards Agency is to conduct further research into the possible link between six food colourings and hyperactivity in children, following calls from 42 organisations across Europe for the European Commission to suspend their use.
    PolandConsumer Protection
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    Interim Period For Borderline Products Expires

    The interim period for borderline products will expire on 31 December 2009 after attempts to extend it failed.
    PolandFood, Drugs, Healthcare, Life Sciences
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    Energy Drinks Not For Persons Under The Age Of 18

    Poland introduces from January 1, 2024 a ban on the sale of energy drinks to persons under the age of 18. It is not a big surprise, considering long lasting discussion in this regard at the EU and national level.
    PolandMedia, Telecoms, IT, Entertainment
    Global Advertising Lawyers Alliance (GALA)
    Global Advertising Lawyers Alliance (GALA)
  • Article

    Fuelling Healthcare Innovation: Poland Creates New Medical Research Agency

    In March 2019, the new law creating a Medical Research Agency ("the Agency") entered into force in Poland. This new entity is intended to play a similar role to institutions like the UK's Medical
    PolandFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    Coronavirus – Q&A And Practical Instruction For Employers In Poland

    This Sunday, March 8 2020 the Act on special solutions related to the prevention, counteracting and combating of COVID-19, other infectious diseases and emergencies caused by them ..
    PolandEmployment and HR
    Hogan Lovells
    Hogan Lovells
  • Article

    New Rules For Life Sciences Industry Against Coronavirus In Poland

    In preparation for situations of crisis caused by a potential spread of the coronavirus, the Polish Parliament has adopted a draft bill that introduces certain new obligations upon...
    PolandFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    New Rules for Issuing Pharmacy Permits in Poland

    On 15 May 2017 the President of Poland executed the Act of 7 April 2017 amending the Pharmaceutical Law (the "Amending Act"), which changes the current regulations of the Act of 6 September 2001 Pharmaceutical Law ..
    PolandFood, Drugs, Healthcare, Life Sciences
    Schoenherr (Schönherr Rechtsanwälte)
    Schoenherr (Schönherr Rechtsanwälte)
  • Showing 1–20 of 27 results

    Next
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics